Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
172
Participants
Timeline
Start Date
August 31, 2002
Conditions
Colorectal Cancer
Interventions
DRUG
Capecitabine, Oxaliplatin
Trial Locations (1)
SM2 5PT
Royal Marsden Hospital, Sutton
All Listed Sponsors
lead
Royal Marsden NHS Foundation Trust
OTHER
NCT00220116 - Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | Biotech Hunter | Biotech Hunter